.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
US Army
Daiichi Sankyo
Boehringer Ingelheim
Farmers Insurance
McKinsey
AstraZeneca
Dow
Cerilliant
Fuji

Generated: September 22, 2017

DrugPatentWatch Database Preview

BANCAP Drug Profile

« Back to Dashboard

What is the patent landscape for Bancap, and what generic Bancap alternatives are available?

Bancap is a drug marketed by Forest Pharms and is included in two NDAs.

The generic ingredient in BANCAP is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Eighty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.

Summary for Tradename: BANCAP

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list99
Patent Applications: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BANCAP at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Pharms
BANCAP
acetaminophen; butalbital
CAPSULE;ORAL088889-001Jan 16, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Forest Pharms
BANCAP HC
acetaminophen; hydrocodone bitartrate
CAPSULE;ORAL087961-001Mar 17, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
Julphar
US Department of Justice
AstraZeneca
Dow
Boehringer Ingelheim
McKesson
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot